Respecting the reduced LH/FSH action in advanced maternal age women most interviewees agreed that these patients have their gonadotropin deficiency exacerbated (66.7% and 85.7% in the first and second rounds, respectively). This evidence concerns the gene BRD2 and Gonadotropin deficiency.